A traditional Chinese medicine composition for treating heart failure and cardiac autonomic neuropathy

Abstract

The invention provides a traditional Chinese medicine composition for treating heart failure and cardiovascular autonomic neuropathy and belongs to the field of traditional Chinese medicines. The traditional Chinese medicine composition comprises 15-30g of pilose asiabell root, 20-30g of radix astragali, 10-15g of cassia twig, 10-15g of white peony root, 20-30g of tuber of dwarf lilyturf, 15-20g of bighead atractylodes rhizome and 6-9g of licorice root. The traditional Chinese medicine composition has functions of invigorating energy and nourishing heart, regulating ying and wei, improving heart functions, keeping heart sympathetic nerve-pneumogastric nerve balance, substantially improving heart functions and heart rate variability and adjusting heart nerve functions and is especially suitable for patients suffering from yin-wei disharmony-type cardiovascular autonomic neuropathy.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine and relates to a traditional Chinese medicine composition for treating heart failure and cardiac autonomic neuropathy. Background technique [0002] Heart failure is the terminal state of many heart diseases, and the 5-year survival rate is similar to that of malignant tumors. The mortality rate of patients with cardiac function grade IV (NYHA classification) can reach 40% to 50%, and the 5-year mortality rate of patients with uncontrolled heart failure can reach 62%. Cardiac autonomic neuropathy is a common complication that can be seen in various heart diseases and diabetes. In heart failure, not only cardiomyocytes are necrotic and remodeled, but the autonomic nerves of the heart are also damaged. Damage to the autonomic nerves of the heart can aggravate the progression and severity of heart failure, and seriously affect the prognosis and quality of life of patients. Clinically, it...

AI Technical Summary

Problems solved by technology

[0003] At present, the treatment methods for heart failure patients and cardiac autonomic neuropathy are relatively limited, and most of them start with improving heart failure and / or delaying neuropathy, which often cannot really treat the decline of cardiac autonomic nerve function and maintain the balance of cardiac autonomic nervous system. Poor, unable to achieve satisfactory therapeutic effect for patients

At present, Western medicine treats cardiac autonomic neuropathy mainly through the following points: 1) α-lipoic acid, which delays the progress of autonomic neuropathy; 2) Methylcobalamin, a derivative of vitamin B12, can stimulate the protein synthesis of nerve membrane cells, improve Nerve conduction velocity; 3) Aldose reductase inhibitory drugs, by delaying but not reversing the progression of diabetic neuropathy; 4) Angiotensin converting enzyme inhibitor (ACEI) drugs can also improve cardiac autonomic neuropathy, can improve cardiac The activity of parasympathetic nerve; 5) β-receptor blockers, diuretics, digoxin and other drugs improve heart failure and heart function, thus affecting nerve function

The above drugs mainly delay the progression of the disease and protect the nerve function. They cannot maintain or regulate the balance of the autonomic nervous system, and cannot cure the disease.

Images